Ownership history in Siren, L.L.C. · 6 quarters on record
This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Edgewise Therapeutics Inc (EWTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 4,529,990 | +632,891 | +16.2% | 3.35% | $112.4M | $24.82 |
| 2025 Q3 | ADDED | 3,897,099 | +736,801 | +23.3% | 2.47% | $63.2M | $16.22 |
| 2025 Q2 | ADDED | 3,160,298 | +1,463,854 | +86.3% | 2.14% | $41.4M | $13.11 |
| 2025 Q1 | ADDED | 1,696,444 | +962,101 | +131.0% | 2.12% | $37.3M | $22.00 |
| 2024 Q4 | ADDED | 734,343 | +330,230 | +81.7% | 0.87% | $19.6M | $26.70 |
| 2024 Q3 | INITIATED | 404,113 | — | — | 0.54% | $10.8M | $26.69 |
As of 2025 Q4 — sorted by position size